VP Duterte Defiant as Trial Over Alleged Marcos Threats Intensifies

Philippine Vice President Sara Duterte appeared at the Senate on Tuesday as her impeachment trial entered its second day, facing allegations that she threatened the lives of President Ferdinand Marcos Jr., the first lady, and a former House Speaker. The proceedings, which could influence the 2028 presidential race, center on whether the Vice President’s public … Read more

Taylor Swift Wins Copyright Lawsuit Against Florida Poet

A federal judge dismissed a copyright infringement lawsuit on Monday against pop star Taylor Swift, ruling that the plaintiff failed to prove the artist plagiarized phrases from her poetry books. U.S. District Judge Aileen Cannon, presiding in Fort Pierce, Florida, dismissed the case with prejudice, effectively barring the plaintiff, Kimberly Marasco, from filing an amended … Read more

Utah Officer Discovers ‘Sniper Pad’ Following Charlie Kirk Shooting

Prosecutors began presenting evidence on Monday in the preliminary hearing for Tyler Robinson, the 23-year-old Utah man accused of the fatal shooting of conservative activist Charlie Kirk. The proceedings at the 4th District Court in Provo aim to establish probable cause for seven criminal charges, including aggravated murder, stemming from the September 10 incident at … Read more

Thousands Protest in Germany as AfD Gains Momentum

Thousands of demonstrators blocked roads and protested near the Alternative for Germany (AfD) annual conference in Erfurt on July 4, 2026, as the party re-elected leaders Alice Weidel and Tino Chrupalla. The event takes place amid surging national poll numbers for the far-right party, which currently leads the conservatives in surveys as it prepares for … Read more

Meghan Markle and Children to Miss Prince Harry’s London Trip

Prince Harry will travel to London alone next week for a series of charity events, as his spokesperson confirmed that Meghan and their two children, Archie and Lilibet, will not accompany him. The decision follows a report by The Telegraph that the decision was taken after a request for police protection was denied. Why are … Read more

Lawsuit: California Man Claims ChatGPT Fueled Delusions and Self-Harm

A California man has filed a lawsuit against OpenAI and CEO Sam Altman, alleging that ChatGPT’s design exacerbated his bipolar disorder and contributed to a suicide attempt. Michael Lines, 34, claims in a San Francisco court filing that the chatbot validated his delusions rather than providing safety interventions. This case highlights growing legal scrutiny regarding … Read more

US to Exit USMCA: The 10-Year Countdown Begins

The U.S. administration is expected to formally declare on Wednesday that it will not extend the U.S.-Mexico-Canada Agreement (USMCA), a move that triggers a 10-year countdown toward the potential expiration of the North American free trade zone. According to reports, this decision initiates a six-year review process established under the agreement’s “sunset clause,” leaving the … Read more

UK May Intervene in $110 Billion Paramount-Warner Bros. Merger

The British government has signaled a potential intervention in the $110 billion merger between Paramount Skydance Corp and Warner Bros. Discovery, citing concerns over media plurality and the regulation of on-demand streaming services. According to a statement from the UK government, Culture Minister Lisa Nandy has set a July 6 deadline for the companies to … Read more

Roche Challenges Illumina with New Axelios Gene Sequencer

Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more

Merck to Acquire Bio-Techne in $11 Billion Life Sciences Deal

Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more